Levetiracetam Tablet, Film Coated
Product Images NDC 31722-538

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 31722-538). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Leveannora1000mg30scount

Label for Levetiracetam Tablets, USP 1000 mg by Camber Pharmaceuticals, Inc. The film-coated tablets are in a package containing 30 tablets. The label includes storage instructions, pharmacist dispensing guidance, a barcode, and the manufacturer information indicating Annora Pharma Pvt. Ltd. in India and Camber Pharmaceuticals, Inc. in New Jersey.*

FDA Label Image

Leveannora250mg30scount

Label for Levetiracetam Tablets, USP 250 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label includes the NDC 31722-536-30 and states a package size of 30 tablets. It highlights pharmacist instructions, storage conditions, and contact information, with a barcode on the right side.*

FDA Label Image

Leveannora500mg30scount

Levetiracetam Tablets, USP 500 mg film-coated tablets in a 30-count bottle label by Camber Pharmaceuticals, Inc. The label includes the NDC 31722-537-30, storage instructions, pharmacist dispensing guidance, and a U.S. contact number. Manufactured for Camber Pharmaceuticals, Piscataway, NJ.*

FDA Label Image

Leveannora750mg30scount

Label for Levetiracetam Tablets, USP 750 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label shows 30 tablets per container and includes storage instructions, pharmacist dispensing guidelines, a barcode, and manufacturer information including Annora Pharma Pvt. Ltd. in India and Camber Pharmaceuticals in New Jersey.*

FDA Label Image

Levecamber1000mg30scount

Levetiracetam 1000 mg film-coated tablets label by Camber Pharmaceuticals, Inc. The label indicates 30 tablets per container with instructions for pharmacists regarding dispensing in a light-resistant container with child-resistant closure. It includes storage conditions, a pharmacist contact number, and a medication guide URL. The label also states Rx Only and lists manufacturing details.*

FDA Label Image

Levecamber250mg30scount

Levetiracetam 250 mg film-coated tablets label from Camber Pharmaceuticals, Inc. The label displays the proprietary and generic name, dosage strength, and quantity of 30 tablets. Includes storage instructions, pharmacist dispensing information, a barcode, manufacturer details, and a note requiring patients to receive the accompanying medication guide. The label has a designated unvarnished area measuring 40 x 30 mm.*

FDA Label Image

Levecamber500mg30scount

Label for Levetiracetam Tablets, USP 500 mg film-coated oral tablets by Camber Pharmaceuticals, Inc. The label shows the NDC 31722-537-30, a 30-tablet package, and instructions for the pharmacist including dosage storage and medication guide availability. It includes contact and manufacturing information with a barcode on the right side.*

FDA Label Image

Levecamber750mg30scount

Levetiracetam Tablets, USP 750 mg film-coated oral tablets by Camber Pharmaceuticals, Inc. The label includes storage instructions, pharmacist dispensing advice, medication guide availability, and a package count of 30 tablets. It also displays the NDC 31722-538-30 and manufacturer details for Camber Pharmaceuticals in Piscataway, NJ.*

FDA Label Image

Levecamberlogo1

FDA Label Image

Levefig1

A bar chart comparing the percentage of patients across three groups: placebo, Levetiracetam 1000 mg daily, and Levetiracetam 3000 mg daily. The percentage values rise from placebo to the higher dosage groups, showing an increasing trend in patient response or outcome.*

FDA Label Image

Levefig2

A bar chart showing the percentage of patients for placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day groups. The chart compares patient response rates across these three categories, with values visually represented as bars.*

FDA Label Image

Levefig3

A bar chart comparing the percentage of patients between two groups: Placebo (N=104) with 14.4% and Levetiracetam 3000 mg/day (N=180) with 39.4%. The vertical axis represents the percentage of patients from 0% to 45%. This chart illustrates patient response rates associated with the treatment groups.*

FDA Label Image

Levefig4

A bar chart comparing the percentage of patients between placebo and Levetiracetam groups, showing a higher percentage for Levetiracetam. The x-axis represents the treatment groups (Placebo and Levetiracetam), and the y-axis represents the percentage of patients, with values up to 45%.*

FDA Label Image

Levefig5

A bar chart comparing the percent of subjects responding between placebo and Levetiracetam groups. The chart shows approximately 45.2% response for placebo (N=64) and 72.2% response for Levetiracetam (N=79).*

FDA Label Image

Levefig6

A bar chart comparing the percent responders between the placebo group (n=64) and the Levetiracetam group (n=79). The placebo group shows a response rate of 45.2%, while the Levetiracetam group shows a higher response rate of 72.2%.*

FDA Label Image

Levestructure

Chemical structure of Levetiracetam, showing its molecular configuration including a pyrrolidone ring and associated functional groups, consistent with the active ingredient Levetiracetam.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.